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Bioactive glass scaffolds (70S30C; 70% SiO2 and 30% CaO) produced by a sol–gel foaming process are
thought to be suitable matrices for bone tissue regeneration. Previous in vitro data showed bone matrix
production and active remodelling in the presence of osteogenic cells. Here we report their ability to act
as scaffolds for in vivo bone regeneration in a rat tibial defect model, but only when preconditioned. Pre-
treatment methods (dry, pre-wetted or preconditioned without blood) for the 70S30C scaffolds were
compared against commercial synthetic bone grafts (NovaBone and Actifuse). Poor bone ingrowth
was found for both dry and wetted sol–gel foams, associated with rapid increase in pH within the scaf-
folds. Bone ingrowth was quantiﬁed through histology and novel micro-CT image analysis. The percent-
age bone ingrowth into dry, wetted and preconditioned 70S30C scaffolds at 11 weeks were 10 ± 1%,
21 ± 2% and 39 ± 4%, respectively. Only the preconditioned sample showed above 60% material–bone con-
tact, which was similar to that in NovaBone and Actifuse. Unlike the commercial products, precondi-
tioned 70S30C scaffolds degraded and were replaced with new bone. The results suggest that bioactive
glass compositions should be redesigned if sol–gel scaffolds are to be used without preconditioning to
avoid excess calcium release.
 2013 The Authors. Acta Materialia Inc. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction product NovaBone, crystallises on sintering [22], producing a glassSevere bone injuries occurring as a result of trauma, surgically
removed tumours or age-related disorders often lead to osseous
non-unions and loss of structural integrity of the bone [1,2]. Many
synthetic bone grafting materials have been used for the repair and
restoration of skeletal defects, including metals [3,4], polymers [5–
7], composites [8–10], hydroxyapatite (HA) [11–13], calcium phos-
phate [14,15], bioactive glasses (BGs) [16] and glass ceramics [17–
19]. Actifuse (Baxter Healthcare, Newbury, UK), composed of por-
ous silicon substituted HA granules (3 mm), is one of the most
successful synthetic bone grafting materials [20]. While BG has
long been thought to bond more rapidly with bone than HA
[16,18,19,21], porous glasses with suitable pore networks and
mechanical properties were not developed until recently. One rea-
son is that the original Bioglass composition, available as theceramic and changing the material properties. Porous glasses have
been produced by the sol–gel foaming process, which produced
amorphous glass scaffolds with compressive strengths of 2.4 MPa
with a modal interconnect (windows between the pores) diameter
of >100 lm [23,24].
The mechanism of bioactivity for any material is dependent
upon its surface chemistry, ionic dissolution rate and topology
[25]. BGs are thought to bond to bone rapidly due to the rapid for-
mation of a hydroxycarbonate apatite (HCA) surface layer upon
contact with body ﬂuid [21,26] and are thought to stimulate osteo-
genesis via their dissolution products. Soluble silica and calcium
ions are proposed to both activate and stimulate osteoprogenitor
cells at the implant site [27–31]. Sol–gel-derived glasses have an
inherent mesoporosity that gives them a larger surface area and
potentially more rapid degradation rates than melt-derived glasses
of similar composition [30,32–34].
In vitro studies using sol–gel-derived BG foams showed that
these scaffolds could stimulate primary human osteoblasts to pro-
duce mineralized bone nodules without the need for the osteo-
genic supplements dexamethasone and b-glycerophosphate
[29,35]. 70S30C scaffolds induced extracellular matrix formation
by differentiating murine osteoblasts, as well as promotion of C7
macrophage differentiation into osteoclasts and subsequent
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of the scaffold as bone regenerates [36]. However in vivo studies
have been limited to sol–gel particles [37], balls [38] or dense
monoliths [16]. An in vivo study by Wang and co-workers on
70S30C BG reported soft tissue inﬁltration within the porous scaf-
fold in a rabbit subcutaneous model; however, the research ﬁnd-
ings were based on poor histological evidence and lacked
reliability [39]. Moreover, the ability of the scaffold to permit soft
tissue ingrowth within the pores does not well predict the bone-
forming potential of the material.
Here we evaluate the potential of a sol–gel-derived 70S30C
(70% SiO2, 30% CaO) BG as a candidate scaffold for bone regenera-
tion by investigating its osseo regenerative potential in a rat tibial
defect model. As wetting or preconditioning of BGs in physiological
ﬂuids has been shown to affect their biological response [40–42],
we evaluated porous 70S30C BG foams following a variety of pre-
treatment methods (dry, pre-wetted or preconditioned).The
hypothesis was that increasing the length of time for pretreatment
would reduce the amount of calcium dissolution from the glass and
hence reduce the pH burst as described in our in vitro studies.
We also compared new bone formation in tibial defects ﬁlled
with the 70S30C scaffolds to those ﬁlled with: commercially avail-
able NovaBone (melt-derived Bioglass particles); Actifuse (Si-HA
porous granules); or 70S30C foam granules ground to match the
size of the Actifuse. All these granular samples were pre-mixed
with autologous blood prior to implantation, which is usual prac-
tise for orthopaedic surgery. Unﬁlled defects (both with and with-
out autologous clotted blood) served as controls for the study. New
bone formation was analysed ex vivo at 11 weeks using quantita-
tive three-dimensional (3-D) microcomputed tomography (mi-
cro-CT) imaging, histomorphometry and immunohistochemistry.2. Materials and methods
2.1. Materials
The 70S30C (70 mol.% SiO2 and 30 mol.% CaO) BG used in this
study was prepared by the sol–gel foaming technique [23]. The
sol was prepared by hydrolysis of tetraethyl orthosilicate (TEOS)
in the presence of nitric acid, with calcium nitrate tetrahydrate
as the calcium source (all from Sigma; Gillingham, UK). The molar
ratio of water to TEOS (R ratio) was 12:1.
Porous scaffolds were produced by foaming 50 ml aliquots of
sol by vigorous agitation with the addition of 0.35 ml Teepol (Har-
vey Waddington Ltd, UK) and 1.5 ml 5% (v/v) HF (a gelation cata-
lyst). Teepol is a detergent containing a low concentration
mixture of anionic (15%) and non-ionic surfactants (5%). As the gel-
ling point was approached, the foamed solution was cast into
cylindrical poly-methyl propylene moulds. Samples were aged
(60 C), dried (130 C), thermally stabilized (600 C) and sintered
at 800 C for 2 h.
It was important to compare the scaffolds to commercially
available BG (NovaBone) and the leading porous HA scaffold (Acti-
fuse). NovaBone was donated by NovaBone Products LLC (Alachua,
USA) and is a melt-derived 45S5 Bioglass (46.1 mol.% SiO2,
24.4 mol.% NaO, 26.9 mol.% CaO and 2.6 mol.% P2O5) with particu-
late size typically ranging between 70 and 910 lm. Actifuse is a
porous silicon substituted HA (0.8 wt.% Si) purchased from Baxter
Healthcare, Newbury, UK) with granule sizes typically between 1
and 3 mm.2.1.1. Material characterization
Foam scaffolds were produced to a bulk density of
0.25 ± 0.03 g cm3 (measured geometrically) and a percentage
porosity of 90 ± 12%. The porosity value was calculated from thebulk density and the skeletal density (measured from helium pyc-
nometry as 2.7 g cm3) and therefore includes nanoporosity inside
the struts of the scaffold (interconnected pores of 12 nm modal
diameter, according to gas sorption analysis). Therefore the per-
centage porosity accessible to bone is smaller than 90%. 3-D images
of the macroporous structures of the 70S30C scaffolds were ob-
tained by the use of X-ray micro-CT (Nano-focus, Phoenix X-ray
GE, Measurement & Control, Wunstorf, Germany) with
9 lm voxel1 resolution. 3-D image analysis methods were devel-
oped in-house and applied to the images to obtain size distribu-
tions of the pore and interconnect diameters (see Refs. [24,43–
46]). The distribution of interconnect diameters was validated
using mercury intrusion porosimetry (Quantachrome Poremaster
33, Quantachrome UK, Fleet, UK; data not shown).
2.1.2. Implant preparation
The 70S30C foams were cut into 3 mm diameter/2 mm thick
discs with the aid of a sterile scalpel blade. The discs were subse-
quently sterilized in dry heat (200 C for 2 h) prior to use. Wetting
and preconditioning of 70S30C implants was performed by immer-
sion in serum-free a-MEM (minimum essential medium)
(1.5 mg BG ml1 media; [36]) in sterile tissue culture plates at
37 C for either 5 min or 3 days, respectively. Vacuum processing
was performed at 10 psi for 5 min to ensure the removal of trapped
air in the BG pores. Both Actifuse granules and NovaBone implants
were prepared by the mixing of particulate with autologous blood.
To obtain 70S30C granules of similar dimensions, 70S30C scaffolds
were cut into three small pieces of approximately equal size
(1 mm3), which were pre-mixed with blood prior to implantation.
In order to assess pH changes as a result of immersion in solution,
dry 70S30C foams (3  3  2 mm) were incubated in serum-free a-
MEM culture medium and the pH of the undiluted eluate measured
at 1, 2, 4, 24 and 72 h at 37 C. After preconditioning (for a total of
72 h), the medium was changed and the pH measured at the same
time points for another 72 h. Three replicates per time point were
measured and mean values calculated.
2.2. Animals and surgical procedures
All animal procedures were approved and conducted in accor-
dance with the appropriate institutional (University of Ulster) ani-
mal care committee and National (UK Home Ofﬁce) guidelines. A
total of 40 male Wistar rats (10–12 weeks old, 300–400 g body
weight) had a single 3 mm diameter sub-critical defect made in
the medial aspect of the right tibia. Rats were injected with an
anaesthetic mixture comprising 2.0 ml Ketaset (100 mg ml1),
1.0 ml Xylapan (20 mg ml1) and 5 ml phosphate buffered saline
(PBS, pH 7.4). Once the animal had reached a deep plane of anaes-
thesia, its lower right leg was shaved with mechanical clippers and
the area cleared of fur by the application of a depilatory cream. The
leg was cleaned with moist gauze and sterilized using three con-
secutive washes of chlorhexidin (Hibisrub, Regent Medical Ltd,
UK), followed by 70% isopropanol. Sub-cutaneous injection of
0.5 mg ml1 Metacam (Boehringer-Ingelheim, Germany) was
administered for palliative pain prevention.
During the surgical procedure, animals were kept warm on a
bespoke heating mat (37 C). A 1.5 cm full-thickness skin incision
was made longitudinally above the middle third of the medial as-
pect of the tibia. The resultant skin ﬂap was opened using ﬁne
spreaders (Interfocus Ltd, UK) exposing the underlying tibia. The
tibial surface was cleared of connective tissue and a 3 mm circular
defect created using a trephine bur, which extended down to the
level of the marrow cavity. The defect site was gently cleared of
blood and bone fragments with the aid of suction and the tissue
kept moist by saline irrigation. Rats were randomly divided into
eight groups of ﬁve rats each as follows; Actifuse, NovaBone and
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70S30C foams, foams wetted for 5 min in a-MEM, preconditioned
foams (3 days in a-MEM) and defect only with or without autolo-
gous clotted blood (Fig. 1). The implants were gently inserted into
the defects by the press-ﬁt technique. Following implantation, the
muscle was secured in place by closed sutures followed by a run-
ning suture for the skin ﬂap. Post-surgery, animals received topical
application of 0.2% chloramphenicol antibiotic solution to the su-
tured skin to prevent contamination of the operated site followed
by an intra-peritoneal administration of 5 ml of 5% dextrose-saline
solution. Rats were housed in well ventilated rooms with 12 h
light:dark cycles and were given access to food and water ad libi-
tum. The animals were euthanized after 11 weeks, their tibiae har-
vested and tissues subsequently processed for micro-CT, histology
or immunohistochemistry.
2.2.1. Collection of autologous blood
Immediately prior to tibial surgery, anaesthetized Wistar rats
that were assigned to either the control group or material (+clotted
blood) had their tail swabbed with an alcohol wipe and a small
incision was made in the caudal vein. Blood was immediately col-
lected in heparin coated microvettes (Microvettes CB 300 FH, Ger-
many) by capillary action. To standardize the volume of clotted
blood inserted into tibial defects, the material was placed in the
end of a tip-less 1 ml syringe (Terumo, Belgium) and a 100 ll ali-
quot of autologous whole blood was added to the scaffold. Mixing
of blood was ensured by repeated pipetting, with clotting consis-
tently observed after 3–4 min. Controls consisted of clotted blood
only. To ensure aseptic transfer, the clot (±) scaffold was pushed
out of the syringe and into the defect.
2.3. Microtomography analysis
At 11 weeks post-surgery, rats were euthanized and the sam-
ples were subsequently ﬁxed in a solution of 10% buffered formal
saline for 48 h. From each group of ﬁve rats with an implanted bio-
material, two randomly chosen rat tibiae were carefully dissected
free of muscle and connective tissue and prepared for micro-CT
scanning. The tibiae were scanned at 70 kV, 100 lA at a resolution
of 9 or 11 lm voxel1. An optical ﬁbre of known density was
scanned together with the samples to allow intensity normalisa-
tion of the images. The 3-D images of the scaffold–host bone were
obtained using Avizo Image processing software (Visualisation Sci-
ences Group, Merignac Cedex, France).Fig. 1. Surgical site on the medial surface of rat tibia showing a 3 mm circular
defect ﬁlled with clotted blood.In order to compare equivalent regions between different sam-
ples, a convex hull algorithm [47] was used to ﬁnd the region-of-
interest (ROI) bounded by the biomaterial phase (Fig. 2 and Supple-
mentary Fig. 1). Only the volume and surface area of the bone and
biomaterial within this region was considered. After segmentation,
a marching cubes algorithm [48] was used to calculate the volumes
and surface areas. The percentage of bone ingrowth refers to the
volume of bone inside the ROI and the percentage contact area is
the proportion of biomaterial surface area in contact with bone
within the ROI.
2.4. Sample preparation for microscopic analysis
To process tibiae for histology, formalin ﬁxed samples were
decalciﬁed by immersion in 14% di-sodium EDTA (Sigma–Aldrich,
UK) pH 9.0 under constant agitation at 5 rpm on a roller mixer at
room temperature. The decalciﬁcation solution was changed three
times a week for 14 days and the samples were subsequently
dehydrated in ascending grades of ethanol, cleared in xylene and
embedded in parafﬁn.
2.4.1. Histomorphometry
For histological staining, 5 lm thick sections were cut, lifted
onto slides (Superfrost slides; Thermoscientiﬁc, UK) that were pre-
coated with 3-aminopropyl triethoxysilane (Sigma Aldrich, UK)
and stained with haematoxylin and eosin (H&E).
Histomorphometric analysis was performed using the ImageJ
program [49]. For computing the standard medial wall diameter
of the rat tibia, the corresponding left legs of the animals without
the defects were processed in a similar manner to the implanted
(right) legs.
Transverse histological sections of un-operated tibiae were ob-
tained, stained with H&E and examined on a Zeiss Axio Scope A1
Microscope (Nikon, Japan) at a range of objective magniﬁcations.
For evaluation of wall thickness, a longitudinal transect joining
the two farthest points on the tibia was drawn through the centre
of the image to determine the midpoint and a 3 mm region (corre-
sponding to the area of the defect) was delineated on the medial
wall relative to this mid-point. Six measurements, separated by a
distance of 500 lm were taken across the medial wall within this
region of interest. Having computed the mean medial wall diame-
ter of 562 lm (from a total of ﬁve samples, with three sections
measured per sample) with a known defect length of 3 mm, a
quadrilateral corresponding to the standardized defect area of
1.65 mm2 was delineated on the images and this was used to de-
ﬁne the area for analysis of individual tissue components within
the total area of the defect (Fig. 3). The different tissue components
were manually identiﬁed and marked and their areas calculated
using ImageJ software. A total of ﬁve samples were analysed in
the control (no blood), dry 70S30C foams, Actifuse, NovaBone
and preconditioned 70S30C foams. Postsurgical fractures were ob-
served in samples from three groups and measurements of tissue
areas were therefore excluded in these samples: dry granules
(n = 4), controls with blood clot (n = 4) and wet foams (n = 3).
2.4.2. Immunostaining
To detect vasculature in the newly formed bone tissue, speci-
mens were stained with Bandeirea simplicifolia isolectin B1 (Sigma
L2140, UK). Brieﬂy, specimens were cleared in xylene, dehydrated
through a graded alcohol series and subjected to antigen retrieval
by heat treatment with citrate retrieval buffer pH 6.0 (boiled for
5 min at 350 W in a microwave oven) and subsequently cooling
for 20 min at room temperature. After several washes in PBS, the
slides were incubated in two changes of PBLec (1% Triton X-100,
0.1 mM CaCl2, 0.1 mM MgCl2, 0.1 mM MnCl2 in PBS; pH 6.8) for
5 min each and stained with 20 lg ml1 Isolectin biotin conjugate
Fig. 2. Image processing steps used prior to quantiﬁcation of bone ingrowth and contact area in an Actifuse sample. (A) A 3-D reconstruction of the middle third of the rat
tibia (yellow) with the ROI (blue) determined by applying convex hull to the biomaterial. The volume and surface area of the bone (yellow) and biomaterial (green) inside the
ROI are calculated in (B). Scale bar in A and B is 1 mm. (C) A top-down view slice through the ROI and bone, with the ROI outlined in blue. (D) The contact area between the
bone (grey) and biomaterial (white) as a red outline.Scale bar in C and D is 500 çm.
Fig. 3. Light micrographs of H&E stained medial transverse sections showing the
areas selected for quantitative analysis from a tibia implanted with dry 70S30C
granules (A) or NovaBone (B). To assess equivalent areas across the groups, the
average medial wall tibial diameter (562 lm) in addition to the lesion size (3 mm)
was determined on each section. Bone (red lines); material (black lines); ﬁbro-
inﬂammatory tissue (arrow); ﬁbrous tissue (arrowhead). Scale bar = 1.3 mm.
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streptavidin conjugate (Molecular Probes, Invitrogen; 1:100 dilu-
tion) was used as the secondary antibody, followed by nuclear
staining with 100 lg ml1 DAPI (40,6-diamidino-2-phenylindoledihydrochloride; Sigma, UK) for 10 min. The specimens were
mounted with Mowiol 4–88 anti-fade solution (Sigma, UK) and
sealed with a coverslip. Images were captured at a range of objec-
tive magniﬁcations using a Leica SP5 confocal microscope (Leica
Microsystems: Germany) and SP5 LAS IF Software.
To detect osteoclast activity, tartrate resistant acid phosphatase
staining (TRAP kit, procedure No. 387: from Sigma–Aldrich, UK)
was performed on parafﬁn sections post antigen retrieval (see
above) according to the manufacturer’s instructions.
2.5. Statistical analysis
After testing the results for normality using the Kolmogrov–
Smirnov test, one-way Anova followed by the Tukey HSD post-test
was applied to all data sets. Statistical analysis was performed
using GraphPad Prism6 software (Intuitive Software for Science,
San Diego, CA, USA). Results were expressed as mean ± SEM and
were considered statistically signiﬁcant if p < 0.05.
3. Results
3.1. Characterization of pore networks in porous implants
The reconstruction and subsequent characterization of pore and
interconnect structures as determined following micro-CT scan-
ning and analysis is shown for a representative 70S30C sample in
Fig. 4. Material characterization employing micro-CT showing (A) reconstruction of a child volume of the 70S30C foam; (B) the separated pores from a child volume of a piece
of 70S30C; (C) distribution of interconnect sizes displayed as area fraction (for interconnects); (D) distribution of interconnect sizes displayed as area fraction. (E)
Interconnect and pore size distributions of 70S30C and Actifuse determined from micro-CT images.Scale bar = 400 lm.
Table 1
pH values of 70S30C conditioned media following immersion.
Time (h) pH
Media (0) 7.3
1 7.47
2 7.55
4 7.59
24 7.87
72 8.19
Media (72) 7.3
73 7.34
74 7.34
76 7.37
96 7.48
144 7.5
The pH of conditioned a-MEM added to 70S30C foams and
incubated at 37 C was measured in the solution directly
around the foams. A total of three separate measures from
each time point were made and data represented as the mean
of these values. After immersion of NovaBone and Actifuse for
72 h, pH was 7.64 and 6.65, respectively.
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a highly porous, interconnected foam structure. Application of the
dilation and watershed algorithms revealed spherical shaped pores
(Fig. 4B). Fig. 4C shows a micro-CT image of an Actifuse granule.
Fig. 4D and E shows the interconnect pore and size distributions
from analysis of the micro-CT images. The modal pore diameter
was 300 lm and modal interconnect diameter 120 lm. Over 96%
of the pore volume comprised pores where the diameter is 100–
400 lm and 54% of the interconnect area consisted of intercon-
nects with a diameter P100 lm (Fig. 4D).
3.2. Preconditioning the scaffolds
The pH of the solution surrounding 70S30C foams at 72 h after
preconditioning was found to be 8.12 and following washing and
replacement with fresh media for a further 72 h, the pH was re-
duced to 7.5 (Table 1). This implies that the pH inside foams
in vivo was higher for the untreated implants compared to those
that were preconditioned. Immersion of NovaBone particles in
the media for 3 days caused the pH to rise to 7.64. In contrast,
the Actifuse caused the pH to drop to 6.65. Our previous study
on the effect of dissolution on the pore network using micro-CT
showed little change at 72 h [45]. FTIR of 70S30C scaffolds after
preconditioning also showed no HCA precipitation on the surface
[29].
3.3. Bone healing in control tibiae
The micro-CT micrographs in Fig. 5 demonstrate features of a
3 mm intramedullary rat tibial control defect (without implanted
biomaterial). On the day of surgery, ex vivo scans revealed a uni-
form full-thickness defect, which at its mid-point spanned the en-
tire medial tibial wall (Fig. 5A–C). After 11 weeks of healing,closure of the defect with new bone (of similar density to old bone)
was evident in both the defect-only (Fig. 5D–F) and blood clot con-
trol (Fig. 5G–I) groups.
Examination of histological sections from defect-only control ti-
biae (Fig. 6A) or those implanted with blood clots (Fig. 6B) revealed
dense new bone formation with a morphological resemblance to
cortical bone. The wall diameters (mean ± SEM) observed in de-
fect-only (Fig. 6A: wall diameter 553 ± 27 lm, n = 5) or blood clot
ﬁlled (Fig. 6B: 539 ± 19 lm, n = 4) defects were similar to that of
non-operated tibia (562 ± 13 lm, n = 5). The defect margins could
not be readily identiﬁed due to complete osseous union of the
operated site in either of the control groups.
Fig. 5. Top panel: Series of 3-D rendered micro-CT images (A, D and G) showing the location of longitudinal sections (B, E and H) and transverse sections (C, F and I) from
control defects. (A–C) Representative images of a 3 mm tibial defect at day 0; (D–F) at 11 weeks, closure of the defects occurs in both defect-only controls and; (G–I) controls
with a blood clot inserted. Scale bar is 1 mm in 3D images (A, D, G) and 0.5 mm for 2D images (B, C, E, F, H, I).
Fig. 6. Light micrographs of H&E stained transverse sections from the centre of the defect in control groups (sampled at 11 weeks post-surgery) which display complete bony
union in: (A) defect without blood clot and (B) defect containing a blood clot. Separation of the bone marrow from the tibial wall is a processing artefact. Abbreviations:
p = posterior, l = lateral and m = medial (defect site) tibial wall. Scale bar = 500 lm.
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S. Midha et al. / Acta Biomaterialia 9 (2013) 9169–9182 91753.4. Bone healing in defects implanted with biomaterials in granular/
particulate form
3.4.1. Actifuse
3-D micro-CT images of implanted rat tibiae with correspond-
ing longitudinal and transverse sections at the mid-plane are illus-
trated in Fig. 7. Actifuse granules revealed almost complete
regeneration of the defect site with new osseous tissue of similar
density to the surrounding pre-existing bone (Fig. 7A–C). In addi-
tion, Actifuse granules intruded into the medullary cavity
(Fig. 7B) and low attenuation material observed around the periph-
ery of the pores indicated bone formation within the marrow cav-
ity (Fig. 7B). Micro-CT analysis showed a total of 43% of the ROI was
ﬁlled with new bone tissue and the Actifuse material ﬁlled 27% of
the ROI space (Table 2). Extensive bone formation was observed on
the Actifuse as 61% of its surface area was in contact with bone
(Table 2).
In the Actifuse implant group, examination of H&E sections re-
vealed that the defect site was completely occupied by new bone
tissue that was continuous with the pre-existing wall (Fig. 8A). For-
mation of the new bone occurred in close proximity to the Actifuse
granules, as indicated by both micro-CT (Fig. 7A–C) and histology
(Fig. 8A). New bone formation that was continuous with the pre-
existing tibial wall was observed in the defect area. Two distinct
patterns of bone formation were seen around the material inside
the medullary cavity: thin bone septa formed along the periphery
of some pores delimiting bone marrow, while small bony islands
were deposited within the pores of other granules (Fig. 8A). A thin
layer of ﬁbrous connective tissue was consistently observed over
the surface of the new bone.3.4.2. NovaBone
All defects implanted with NovaBone demonstrated complete
osseous union in the 11 week ex vivo samples (Fig. 7D–F). Particles
were completely embedded within this new bone tissue, corre-
sponding to 60% of the new bone ﬁlling the ROI space (Table 2). Di-
rect apposition of new bone with the NovaBone particles was also
evident (Fig. 7E and F), consistent with 67% of the particle surface
area in contact with bone tissue (Table 2). Extensive bone forma-
tion was also seen around particles located inside the medullary
cavity (Fig. 7E).
Dense cortical bone formation was also observed following his-
tological analysis (Fig. 8B) and numerous blood vessels containing
erythrocytes were seen within the defect site. NovaBone particles
(which did not take up H&E stain) were completely surrounded
by new bone formation both within the defect area and inter-
spersed through the medullary cavity (Fig. 8B). The medullary cav-
ity could not be distinguished from the original defect area due to
this contiguous bone formation. Several particles formed clefts,
which in most cases were associated with mature bone tissue con-
taining osteocytes (Fig. 8B; inset). A thick ﬁbrous connective tissue
layer also formed on the external surface of the new bone covering
the area of the lesion (Fig. 8B).Table 2
Summary of the quantiﬁcation results using the methodology described in Fig. 2.
Group Pretreatment % material in ROI % bone ingrow
70S30C Dry scaffold 12 ± 2 10 ± 1
Granules with blood 14 ± 2 27 ± 2
Scaffold wetted 12 ± 2 21 ± 2
Scaffold preconditioned 8 ± 2 39 ± 4
Commercial Novabone with blood 10 ± 6 60 ± 7
Actifuse with blood 27 ± 5 43 ± 5
The proportion of bone inside the ROI region (% bone ingrowth) and proportion of biom3.4.3. 70S30C granules
No evidence of osseointegration was found following micro-CT
analysis of dry 70S30C BG granules (Fig. 7G–I), resulting in non-
closure of the defect site. Granules could also be seen within the
medullary cavity, with no evidence of hard tissue deposition in
the pores. Separation of the dry material from the adjacent bone
tissue was conspicuous (Fig. 7H and I) and only 12% of the material
surface area was in contact with bone (Table 2).Thickening of the
medial wall at the defect margins indicated most bone formation
occurred along the periphery of the defect site being clearly sepa-
rated from the granules (Fig. 7H and I); only 27% of the ROI was
ﬁlled by bone (Table 2).
Histological examination of the defect site showed a dense
mononuclear inﬁltrate, indistinguishable from the bone marrow
and encapsulating the biomaterial (Fig. 8C). Numerous leukocytes,
in addition to multinucleated giant cells (MGCs), characteristic cell
types involved with a chronic inﬂammatory response, were closely
associated with the material surface and were clearly identiﬁed by
light microscopy (Fig. 8C; inset). New bone, with a lamellar struc-
ture, was formed along the marginal area of the defect and a thin
layer of cells aligned along this surface had the typical appearance
of bone lining cells. Fibrous connective tissue formation was con-
sistently seen across the external surface of the defect.3.4.4. Histomorphometry
Defects implanted with dry 70S30C granules had minimal bone
formation with a large area occupied by inﬂammatory tissue
(Fig. 8D). Cortical bone areas were comparable in the lesion areas
of NovaBone, Actifuse and the defect-only control group
(p = 0.92). At 11 weeks, the amount of persistent material was sig-
niﬁcantly less in the NovaBone group (p = 0.007) than that mea-
sured in tibia implanted with either the Actifuse or dry BG
granules (Fig. 8D). Within the defect area of the 70S30C granule
group no ﬁbrous connective tissue was noted, while areas of ﬁ-
brous tissue did not differ between NovaBone, Actifuse and control
(+ blood) groups (p = 0.77; Fig. 8D).3.5. Pretreated 70S30C foams enhance bone formation
3.5.1. Dry foams
As observed with micro-CT, new bone was formed external to
the scaffold and separated the material from the marrow cavity
(Fig. 9A–C). Examination of successive longitudinal micro-CT
images of dry scaffolds revealed a small overlap of bony tissue at
the implant periphery (Fig. 9B) consistent with the ﬁnding that
2% of the material surface was in contact with newly formed bone
(Table 2). A clear zone of separation between the material and
adjacent bone tissue was evident with only 10% of the ROI being
ﬁlled by bone and 12% by 70S30C material (Table 2).
Histological examination of sections from dry foams revealed a
ﬁbro-inﬂammatory inﬁltrate containing abundant leukocytes and
MGCs in the defect area (Fig. 10A; inset), consistent with a chronic
foreign body response similar to the histological pattern for dryth Bone–material contact area (mm2) % material in contact with bone
0.8 2 ± 0.1
9.3 12 ± 1
6.7 10 ± 1
19.7 61 ± 14
45.6 67 ± 18
20.9 61 ± 11
aterial surface area in contact with bone.
Fig. 7. Micro-CT micrographs of rat tibial defects displaying bone formation following implantation of different biomaterials. Top panel: Series of 3-D micro-CT images;
centre panel: longitudinal sections; bottom panel: transverse sections of implanted defects at 11 weeks. From top to bottom, transects shown in the 3-D images denote a
longitudinal and a transverse section of the same tibia, respectively. Bone is dark grey and biomaterial is light grey. (A–C) Actifuse granules with complete bone ingrowth
within the defect site. Note the intrusion of granules inside the medullary cavity, with bone formed around the periphery of the pores (arrow). (D–F) NovaBone particles with
extensive bone formation in both the defect site and the medullary cavity. (G–I) Dry 70S30C granules showing no bone integration; note the material–bone separation at the
interface. Scale bar is 1 mm in 3D images (A, D, G) and 0.5 mm for 2D images (B, C, E, F, H, I).
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were seen around the scaffold, although there was no evidence of
osseointegration within the porous material (Fig. 10A). Immuno-
histochemical staining with GSI-B4 showed that numerous blood
vessels closely associated with the surface of the material
(Fig. 10B). TRAP positive cells were only observed along the defect
margins in association with newly formed bone (Fig. 10C), whereas
abundant MGCs were seen adjacent to the material surface within
the ﬁbro-inﬂammatory tissue.3.5.2. Foams wet for 5 min prior to implantation
The majority of the scaffold in pre-wetted samples (Fig. 9D–F)
was separated from the new bone with only 10% bone–material
contact (Table 2). Formation of thin bone septa occurred mostly
at the periphery of the porous material adjacent to the marrow
cavity (Fig. 9E), consistent with the ﬁnding that only 21% of the
ROI was ﬁlled by bone (Table 2). The newly formed bone was com-
pact, containing osteocytes and a clear lamellar organisation
(Fig. 10D). A layer of ﬁbrous connective tissue was observed adja-
cent to the new bone. Several MGCs were found to be closely asso-
ciated with the surface of scaffold, indicative of a foreign bodyreaction (Fig. 10D). Numerous blood vessels were seen both within
the newly formed bone and throughout the adjacent ﬁbrotic areas
(Fig. 10E). A few TRAP positive cells were noted on the surface of
newly formed bone (Fig. 10F) and these were occasionally associ-
ated with the surface of residual material.3.5.3. Preconditioned foams
Complete osseointegration with the newly formed bone (39% of
the ROI was ﬁlled by new bone; Table 2) and a marked reduction in
material area (8% of the ROI was taken up by 70S30C; Table 2) was
observed in preconditioned scaffolds (Fig. 9G–I). Evidence of direct
bone apposition to the material surface was noted, both from mi-
cro-CT imaging data (Fig. 9G–I) and quantitative analysis (61% of
the material in contact with new bone; Table 2).
After 11 weeks in vivo, histological analysis of samples revealed
thick cortical bone around the residual 70S30C material (Fig. 10G),
resulting in a contiguous osseous bridge across the defect site. The
new bone adjacent to the residual 70S30C material contained
numerous blood vessels (Fig. 10H) and TRAP positive cells, both
on residual material and the newly formed bone (Fig. 10I). Fibrous
connective tissue surrounded the external surface of the material.
Fig. 8. Light micrographs of H&E stained 5 lm thick transverse sections from rat tibiae that were implanted with different biomaterials and sampled at 11 weeks post-
surgery. Note the presence of materials inside the medullary cavity (arrowheads) in all the groups. (A) Actifuse granules and new bone formation completely close the defect
site. Bone deposition is seen within the pores of the material (⁄) and along its periphery (arrows) inside the medullary cavity. Thinning of bone in the centre of lesion is seen
(black line). Empty spaces inside the lesion area and medullary cavity are artefacts generated due to tissue separation and dissolution of granules during processing. (B)
NovaBone particles and new bone completely close the defect and extraneous bone formation occurs inside the medullary cavity. The presence of blood vessels within the
newly formed bone is conspicuous (arrow). Inset (boxed region in 8B) shows bone formed within one of the clefts of a NovaBone particle (arrows indicate osteocytes). (C) Dry
70S30C granules; no osseointegration was observed in the dry scaffold. Some bone formed at the defect margins (asterisks); note the presence of bone lining cells along the
surface of the new bone (arrow). The inset (boxed region in 8C) shows the edge of a 70S30C fragment surrounded by leukocytes and a multinuclear giant cell (arrow).
Abbreviations: BM (bone marrow), F (ﬁbrous tissue), NB (new bone), L (lateral wall) INF (Inﬂammation). Scale bars = 400 lm (A–C), 20 lm (insets). (D) Areas occupied by
speciﬁc tissue types within a defect site from mid-transverse sections of rat tibia. BG granules (dry 70S30C granules) show a reduced extent of bone formation and an
extensive inﬂammatory inﬁltrate. Signiﬁcantly less persistent NovaBone material was found in lesion sites compared to either Actifuse or 70S30C granules. For all groups
n = 5, except dry 70S30C granules and control (n = 4).Bars represent mean ± SEM; bone area, ⁄⁄⁄⁄p < 0.00001, ⁄⁄⁄p < 0.0001, ⁄p < 0.01.
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Defects implanted with dry 70S30C foams had the lowest value
for bone area within the defect site (Table 2: Fig. 10J). Dry foams
contained large areas of inﬂammatory tissue (p < 0.0001), while
signiﬁcantly less inﬂammation was observed in wet and none in
preconditioned foams. No ﬁbrous tissue was detected within the
delineated area of the defect in dry foams and the mean area of ﬁ-
brous tissue was greatest in wet foams (p = 0.007) compared to
preconditioned foam samples. Minimal residual 70S30C material
was observed in preconditioned foams (p < 0.0001) as compared
to either dry or wetted foams (Figs. 9 & 10).4. Discussion
BG foams with a 70S30C composition have previously been re-
ported to possess excellent cytocompatibility in vitro [29,36],
including osteogenic stimulation of primary osteoblasts and
remodelling from osteoclasts, but their potential as suitable scaf-
folds for bone tissue engineering applications had not been deter-
mined in vivo. The scaffolds were expected to perform well, due to
their promising results in vitro and because melt-derived BGs had
out-performed HA ceramic and A/W glass–ceramic implants (pow-
ders and monoliths) in vivo.
However, in the rat tibial defect, the direct implantation of dry
70S30C scaffolds led to no bone ingrowth (Fig. 9A–C). But when the
scaffolds were preconditioned in serum-free culture media for
3 days (without osteogenic supplements) and then implanted,
there was complete bone ingrowth and regeneration of the defect
(Fig. 9G–I). The scaffold also seemed to undergo degradation, un-
like any of the other implants. To determine whether the differencewas due to the wetness of the surface, the scaffolds were dipped in
culture media for 5 min and implanted, but this caused little
improvement in bone ingrowth (Fig. 9D–F). The reason as to why
the preconditioned scaffolds promoted bone ingrowth and the oth-
ers did not is likely to be due to the pH inside the pore network.
This conclusion is supported by observations of the effect of pre-
conditioning on pH of culture media in vitro (Table 1), where the
pH of a-MEM increased to more than 8 over 3 days when the dry
70S30C scaffold was immersed, but when the preconditioned scaf-
fold was immersed it only increased from 7.3 to 7.5, which was
more similar to the effect caused by NovaBone (7.64) under the
same conditions. Degradation of the Actifuse was slow (Fig. 7)
in vivo, but when Actifuse was soaked in a-MEM, the pH decreased
from 7.3 to 6.65 over 3 days. It would be useful to be able to com-
pare the 70S30C scaffolds to scaffolds of the NovaBone (Bioglass)
composition with the same pore structure but unfortunately
45S5 scaffolds that remain amorphous cannot be produced.4.1. Preconditioned scaffolds
In the defects ﬁlled with preconditioned scaffolds, mature bone,
with a lamellar aspect, replaced most of the scaffold in the defect
area (Fig. 10G). The preconditioned scaffolds promoted vascular-
ized new bone formation while simultaneously degrading into
non-toxic by-products with the mean bone area at its highest value
(1.431 mm2) and residual material to the minimum (0.05 mm2)
with no evidence of foreign body reaction or inﬂammation
(Fig. 10I). The percentage of material in the ROI is an indicator of
the dissolution of BG after 11 weeks. The presence of only 8% of
the volume taken up by preconditioned scaffold suggests that the
Fig. 9. Micro-CT micrographs of rat tibial defects displaying bone formation in dry (A–C), 5 min wetted (D–F) and preconditioned (G–I) 70S30C BG foams (PC:
preconditioned). From top to bottom, transects shown in the 3-D images denote a longitudinal and a transverse section of the same tibia, respectively. Top panel: Series of 3-D
micro-CT images; centre panel: longitudinal sections; bottom panel: transverse sections of 70S30C foams at 11 weeks. Bone is dark grey and 70S30C BG is light grey. (A–C)
There is no evidence of osseointegration in dry foams, with bone forming around the scaffold and a small area of bone–material overlap (arrow). (D–F) There is some bone
integration through the periphery of scaffold (arrows). The callus formation in the leg indicates post-surgical fracture. (G–I) There is complete bone integration through the
preconditioned foam with minimal residual material remaining. Scale bar is 1 mm in 3D images (A, D, G) and 0.5 mm for 2D images (B, C, E, F, H, I).
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(Fig. 10J). The total volume of preconditioned 70S30C was
2.27 mm3 before implantation and 0.47 mm3 after 11 weeks, an
80% decrease in the volume over 11 weeks (Table 2). The bone–
material contact area was similar to commercial products (above
60%), which suggests that pretreatment of the 70S30C scaffolds
are an essential step to ensure improved integration.
In contrast, the dry scaffolds triggered a typical foreign body
reaction, characterised by ﬁbro-inﬂammatory tissue and the pres-
ence of multinucleate giant cells adjacent to the implant (Fig. 10C).
Wetting the scaffold for 5 min prior to implantation showed an
improvement over dry implantation but the surface of the material
was predominantly encapsulated in ﬁbro-inﬂammatory material
(Fig. 10D), with less bone apposition corresponding to only 10%.
As the 70S30C scaffolds had the same pore morphologies, the ﬁ-bro-inﬂammatory response was attributed to the burst release of
calcium ions in the dry and wetted scaffolds, which was removed
by the preconditioning step.
4.1.1. Role of calcium dissolution
Apart from providing a 3-D scaffold to allow bone bridging to
take place, the ionic release products liberated from BGs play a cru-
cial role in promoting osteostimulation in situ [27]. But these ions
need to be released at an optimum rate to allow cell signalling and
recruitment for subsequent bone formation in vivo [50]. It is well
known that BGs, particularly sol–gel glasses, release a high concen-
tration of calcium ions in a burst after immersion into media or
body ﬂuid [29,35,36,51]. There was a rapid burst of calcium release
after immersion of 70S30C bulk foams in media, with the pH peak-
ing at 8.12 after 72 h (Table 1), although pH was signiﬁcantly
Fig. 10. Light micrographs of H&E stained 5 lm thick transverse sections from rat tibiae that were implanted with dry (A–C), wetted (D–F) and preconditioned (G–I) 70S30C
foams and sampled at 11 weeks post-surgery. (A) No bone integration was noted in dry foams, instead ﬁbro-inﬂammatory tissue was detected. Inset shows an MGC (boxed
region in A) indicated by an arrow. Bone lining cells are seen along the defect margins (arrow). (B) Isolectin positive blood vessels were particularly prominent next to the
fragmented foam surfaces. (C) In dry foams, MGCs are conspicuous (arrows) next to persistent BG material embedded within ﬁbro-inﬂammatory tissue. TRAP positive cells
are only associated with new bone formation at the margins of the defect (inset). (D) Wet foams form thin bone septa within the periphery of the porous material. Also visible
are parts of material embedded in inﬂammatory tissue. The boxed region in (D) shows MGCs on material surface. (E) Blood vessels are present in the new bone (arrowheads)
and adjacent ﬁbrous tissue (arrows). (F) TRAP positive staining was observed at the bone–material interface. High magniﬁcation shows typical multinucleate osteoclast
morphology. (G) Complete bone integration through scaffold (NB) was visible with thin bone trabeculae formed inside the medullary cavity. Note the presence of residual
70S30C material in the bone (dotted lines) with bone deposition on the material (bold arrows). Bone lining cells also present along the bone margins facing the medullary
cavity (arrow). (H) Isolectin positive blood vessels were prominent within newly formed bone tissue next to residual 70S30C (dotted lines). (I) In preconditioned BG, TRAP
positive cells were clearly seen throughout the new formed bone, often in association with the surface of residual 70S30C. Abbreviations: NB (new bone), BM (bone marrow),
F (ﬁbrous tissue), MGCs (multinucleate giant cells). Scale bars = 400 lm, 20 lm (inset). (J) Histomorphometric analysis of a representative group of dry (n = 5), wetted (n = 3)
and preconditioned (n = 5) 70S30C bulk foams. Bone area was increased and inﬂammatory areas signiﬁcantly decreased in treated groups (wetted and preconditioned)
compared to untreated 70S30C dry foams. Bars represent mean ± SEM; bone area, ⁄⁄⁄⁄p < 0.00001, ⁄⁄⁄p < 0.0001, ⁄⁄p < 0.001.
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burst of ions is not transported away from the implantation site
the pH may be high, which is not permissive to cell attachment
and growth [35,36,51,52]. Prior in vitro studies showed that the
scaffolds release large amounts of calcium ions in the ﬁrst three
days of contact with tissue culture medium and attain a steady rate
of release thereafter. In the in vitro studies that showed extensive
matrix formation on the material surface by osteogenic cells, the
scaffolds were preconditioned for 3 days in Dulbecco’s modiﬁed
Eagle medium prior to seeding cells. When commercial BGs, which
are all melt-derived (e.g. NovaBone) are implanted, the pH increase
is likely to be lower (according to our test in a-MEM) and dynamic
conditions in vivo have been enough to transport the dissolution
products from the site, to avoid a high pH rise. Again, here, Nova-
Bone particles showed good osseointegration (Fig. 7D–F).
Due to the foam structure and inherent nanoporosity (modal
pore size of 12 nm [23]) of the sol–gel foams, the scaffolds have
much higher surface area (42 m2 g1) compared to the NovaBone
particles (0.15 m2 g1; [51]), therefore dissolution of the foam is
more rapid than the particles. When not preconditioned, it is likely
that there was an increase in pH (see Table 1) within the pore net-
work of the scaffolds after implantation, which was not conducive
for cell migration into the scaffolds. Therefore dry 70S30C granules
(Fig. 7G–I) and foams (Fig. 9A–C) could not support cellular adhe-
sion and bone mineralization on their surface.
However, new bone tissue could be seen along the defect mar-
gins in the lesion area but the material–bone interface was clearly
separated by inﬂammatory inﬁltrate marked by the presence of
abundant lymphocytes, MGCs and macrophages in the defect sites
surrounding the dry material (Fig. 10A). A similar inﬂammatory re-
sponse was observed by Hing and co-workers in the case of HA
containing 5% CaO [53] and dense calcium sulphate [54] implanted
in the femoral condyle of rabbits for 3 and 12 weeks, respectively.
The reason, well supported by their in vitro ﬁndings on HA (con-
taining 5% CaO), was attributed to the rapid degradation of Ca ions
from the materials, resulting in an increase of the local pH which
inhibited bone ingrowth in vivo.
In our study, this hypothesis was conﬁrmed by the completely
reciprocal response observed when tibial defects implanted with
preconditioned 70S30C foams demonstrated complete bone in-
growth (Fig. 9G–I). When the scaffold was preconditioned, the ini-
tial burst of Ca is removed (see Table 1) and there is a slower and
more consistent release rate of ions [29,36]. This assertion is con-
sistent with the complete osseointegration by thick cortical bone
observed passing through the porous architecture of the precondi-
tioned foams at 11 weeks in ex vivo samples.
The reason why the preconditioned scaffolds underwent more
degradation than the dry and wetted scaffolds could be due to
the ﬁbrous encapsulation inhibiting the degradation mechanism.
The glass scaffolds degrade mainly by solution mediated dissolu-
tion (cation exchange and then breaking of the silica network). If
ﬂuid ﬂow is blocked by the capsule then degradation will be re-
duced. Our recent study also showed that osteoclasts may get in-
volved in the remodelling process of preconditioned sol–gel
scaffolds [36]. They may also not reach the site due to the capsule.
It is not clear whether they have an effect on melt-derived glass.
To conﬁrm that the osseointegration observed in precondi-
tioned scaffolds was an effect of the pH environment and not just
wetting of the surface in culture medium, ﬁve rats were implanted
with 70S30C foams that were dipped in media for 5 min prior to
implantation. Micro-CT (Fig. 9D–F) and subsequent histological
analysis (Fig. 10D) revealed little evidence of osseointegration
through the periphery of the scaffold. The bone formed exhibited
a signiﬁcantly higher bone area than the dry foams but was still
a much lower area than in the preconditioned foams, validating
the fact that an optimum release rate of ions is critical in determin-ing the in vivo biocompatibility of the scaffold for regulating the
osseointegration mechanism and subsequently resorbing in the
body to form new bone tissue.
4.2. Comparison with NovaBone
The success of NovaBone in repair and regeneration of osseous
defects is presented in several clinical reports involving treatment
of periodontal defects and craniofacial augmentation [55,56].
Implantation of the NovaBone particles into the tibial defect leads
to complete osseoregeneration with dense tissue, characteristic of
lamellar bone (Fig. 8B). The NovaBone was completely embedded
in the new osseous tissue; direct apposition of bone with the par-
ticles was evident in micro-CT (Fig. 7D–F) and histological analysis
(Fig. 8B). The fact that the NovaBone particulates mixed with blood
can be easily moulded and manipulated by the surgeon offers sev-
eral advantages to the usage of the material across a range of clin-
ical applications [22]. However, the small particle size limits its
applications in sites where a stable ﬁxation is possible. We note
that the particles intruded into the marrow cavity from the original
defect area. Due to the osteoinductive nature of NovaBone [57,58],
an extensive network of bone trabeculae was observed inside the
medullary cavity of the animals by the invading particles. Replace-
ment of the marrow cavity with osseous tissue might prove detri-
mental to the functioning of the newly formed bone due to
restriction of the vascular supply. No quantiﬁable dissolution of
the NovaBone was observed, which was in line with previous stud-
ies conducted in the femoral condyle of rabbits with 45S5 Bioglass
(under the trade names of NovaBone or Perioglas) [16,37] for
12 weeks and 1 year respectively.
4.3. Comparison with Actifuse
Application of Actifuse granules in bone regenerative therapy
has shown promising results, with faster bone apposition rates
compared to porous HA in ovine bone defect models over 12 weeks
[59]. In our study, thick cortical bone, well integrated within the
porous granules, was evident in the micro-CT scans (Fig. 7A–C).
The enhanced osteogenesis with Actifuse is due to the soluble sil-
icon component of the material, which is a potent mitogen for
inducing bone formation [12]. Histology conﬁrmed the presence
of dense bone tissue associated with the granules invading the
medullary cavity (Fig. 8A). Inside the medullary cavity, bone for-
mation on Actifuse particles was limited to the surface of the mate-
rial indicating osteoconductivity [54]. Most of the Actifuse material
was still visible in micro-CT scans, occupying 0.253 mm2 area at
the centre of the defect at 11 weeks as conﬁrmed by histomor-
phometry (Fig. 8D) and the high percentage of material remaining
in the ROI from micro-CT quantiﬁcation (Table 2). This was consis-
tent with the results from previous studies suggesting a slow dis-
solution rate of the material [59-61].
From a quantiﬁcation perspective, the important indicators of
successful bone integration, long term healing and stability of the
defect site are the amount of bone ingrowth within the defect area
and the ability of the implant to integrate with the new bone as
represented by the contact area of the material to the host bone.
The volume of bone inside the ROI (representative of the defect
site) was in the range of 1.6–4.1 mm3 (Table 2). For NovaBone
and Actifuse, the effective bone ingrowth inside the pore space
(ROI volume less material volume) was above 60%. As a large pro-
portion of new bone was found inside the medullary cavity, it is
difﬁcult to infer how well these tibiae will heal over much longer
periods of time. The percentage of bone ingrowth into the
70S30C granules, which were only mixed with blood, was less than
the commercial products, but more noticeably, the percentage con-
tact area of the material surface with bone was considerably less:
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preconditioned 70S30C scaffolds did encourage bone ingrowth,
with 61% of the scaffold surface in contact with bone.4.4. Controls
After 11 weeks of healing, the control groups both with and
without blood clots demonstrated complete replacement of the de-
fect site with regenerated bone tissue. Micro-CT (Fig. 5) and histo-
morphometry (Fig. 6) conﬁrmed the formation of cortical bone
tissue and medial wall diameters equivalent to an uninjured tibia,
consistent with a robust regenerative response within control le-
sion areas by 11 weeks. The 3 mm rat tibial defect model used in
this study is not a critical size defect and new bone growth occurs
across the defect site over the course of the experiment. However,
it is an established surgical model used widely for in vivo screening
of materials prior to progress into large animal models [62,63].
Since the ultimate aim is to manufacture materials that are dura-
ble, this model provides valuable information on the long term
in vivo biocompatibility, bone restoration and degradation proper-
ties of the test material.5. Conclusion
Preconditioned 70S30C BG sol–gel foams were very effective in
regenerating a rat tibial defect within 11 weeks, showing robust
bone ingrowth throughout the pore network and degradation of
the scaffold, while maintaining bone–material contact. The pore
network was therefore suitable for bone regeneration. However,
the glass composition is not optimal for scaffold design as scaffolds
that were not pretreated, or were only brieﬂy wetted, showed very
little bone ingrowth.
Bone ingrowth into the preconditioned scaffolds was similar to
that in Actifuse and NovaBone. However the Actifuse and Nova-
Bone granules showed little evidence of material degradation and
also intruded into adjacent marrow cavities, causing ectopic bone
formation. The beneﬁts of the preconditioned 70S30C scaffolds in-
clude: the defect-speciﬁc 3-D geometry kept them in position for
the 11 week period; bone formation did not encroach the marrow
cavity; and enhanced degradation of the scaffold promoted bone
regeneration within the dimensions of the tibial shaft. In foam
scaffolds that were not preconditioned, it is likely that the pH in-
side the pores was high (supported by our in vitro data), due to cal-
cium ion dissolution and insufﬁcient ﬂuid transport to dampen the
pH rise. Therefore if BG scaffolds are to be used without precondi-
tioning, redesign of the composition or calcium release rate is
needed.Acknowledgements
Swati Midha is the recipient of a Vice Chancellors’ Research Stu-
dentship at the University of Ulster at Coleraine. The authors rec-
ognize the support of the Engineering and Physical Sciences
Research Council (EP/I02249X/1, EP/I020861/1) and the Research
Complex at Harwell.Appendix A. Figures with essential colour discrimination
Certain ﬁgures in this article, particularly Figs. 1–10 are difﬁcult
to interpret in black and white. The full colour images can be found
in the on-line version, at http://dx.doi.org/10.1016/j.actbio.2013.
07.014.Appendix B. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.actbio.2013.
07.014.
References
[1] Li B, Aspden RM. Composition and mechanical properties of cancellous bone
from the femoral head of patients with osteoporosis or osteoarthritis. J Bone
Miner Res 1997;12:641–51.
[2] Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and
implications for the pathogenesis and treatment of osteoporosis. Endocr Rev
2000;21:115–37.
[3] Wolff D, Goldberg VM, Stevenson S. Histomorphometric analysis of the repair
of a segmental diaphyseal defect with ceramic and titanium ﬁbermetal
implants: effects of bone marrow. J Orthop Res 1994;12:439–46.
[4] Albrektsson T. Direct bone anchorage of dental implants. J Prosthet Dent
1983;50:255–61.
[5] Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response
and in vivo degradation of selected polyhydroxyacids: polylactides (PLA),
poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-
hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993;27:1135–48.
[6] Meinig RP, Buesing CM, Helm J, Gogolewski S. Regeneration of diaphyseal bone
defects using resorbable poly(L/DL-lactide) and poly(D-lactide) membranes in
the Yucatan pig model. J Orthop Trauma 1997;11:551–8.
[7] Perka C, Schultz O, Spitzer RS, Lindenhayn K, Burmester GR, Sittinger M.
Segmental bone repair by tissue-engineered periosteal cell transplants with
bioresorbable ﬂeece and ﬁbrin scaffolds in rabbits. Biomaterials
2000;21:1145–53.
[8] Kim HW, Lee HH, Knowles JC. Electrospinning biomedical nanocomposite
ﬁbers of hydroxyapatite/poly(lactic acid) for bone regeneration. J Biomed
Mater Res A 2006;79:643–9.
[9] Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive
porous polymer/inorganic composite scaffolds for bone tissue engineering.
Biomaterials 2006;27:3413–31.
[10] Pamula E, Kokoszka J, Cholewa-Kowalska K, Laczka M, Kantor L, Niedzwiedzki
L, et al. Degradation, bioactivity, and osteogenic potential of composites made
of PLGA and two different sol–gel bioactive glasses. Ann Biomed Eng
2011;39:2114–29.
[11] Conz MB, Granjeiro JM, Soares GD. Hydroxyapatite crystallinity does not affect
the repair of critical size bone defects. J Appl Oral Sci 2011;19:337–42.
[12] Hing KA, Revell PA, Smith N, Buckland T. Effect of silicon level on rate, quality
and progression of bone healing within silicate-substituted porous
hydroxyapatite scaffolds. Biomaterials 2006;27:5014–26.
[13] Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in
heterotopic sites of different animal models. Biomaterials 1996;17:31–5.
[14] Campion CR, Chander C, Buckland T, Hing K. Increasing strut porosity in
silicate substituted calcium–phosphate bone graft substitutes enhances
osteogenesis. J Biomed Mater Res B Appl Biomater 2011;97:245–54.
[15] Balaguer T, Boukhechba F, Clavé A, Bouvet-Gerbettaz S, Trojani C, Michiels JF,
et al. Biphasic calcium phosphate microparticles for bone formation: beneﬁts
of combination with blood clot. Tissue Eng A 2010;16:3495–505.
[16] Hamadouche M, Meunier A, Greenspan DC, Blanchat C, Zhong JP, La Torre GP,
et al. Long-term in vivo bioactivity and degradability of bulk sol–gel bioactive
glasses. J Biomed Mater Res 2001;54:560–6.
[17] Merolli A, Leali PT, Guidi PL, Gabbi C. Comparison in in-vivo response between
a bioactive glass and a non-bioactive glass. J Mater Sci Mater Med
2000;11:219–22.
[18] Oonishi H, Hench L, Wilson J, Sugihara F, Tsuji E, Matsuura M, et al.
Quantitative comparison of bone growth behavior in granules of Bioglass, A-
W glass ceramic, and hydroxyapatite. J Biomed Mater Res 2000;51:37–46.
[19] Vogel M, Voigt C, Gross UM, Muller-Mai CM. In vivo comparison of bioactive
glass particles in rabbits. Biomaterials 2001;22:357–62.
[20] Hardenbrook MA, Lombardo SR. Silicate-substituted calcium phosphate as a
bone void ﬁller after kyphoplasty in a young patient with multiple
compression fractures due to osteogenesis imperfecta variant: case report.
Neurosurg Focus 2006;21:1–5.
[21] Oonishi H, Hench L, Wilson J, Sugihara F, Tsuji E, Kushitani S, et al. Comparative
bone growth behavior in granules of bioceramic materials of various sizes. J
Biomed Mater Res 1999;44:31–43.
[22] Chen QZ, Thompson ID, Boccaccini AR. 45S5 Bioglass-derived glass-ceramic
scaffolds for bone tissue engineering. Biomaterials 2006;27:2414–25.
[23] Jones JR, Ehrenfried LM, Hench LL. Optimising bioactive glass scaffolds for
bone tissue engineering. Biomaterials 2006;27:964–73.
[24] Jones JR, Poologasundarampillai G, Atwood RC, Bernard D, Lee PD. Non-
destructive quantitative 3D analysis for the optimisation of tissue scaffolds.
Biomaterials 2007;28:1404–13.
[25] Jell G, Stevens MM. Gene activation by bioactive glasses. J Mater Sci Mater Med
2006;17:997–1002.
[26] Hench LL, Paschall HA. Direct chemical bond of bioactive glass–ceramic
materials to bone and muscle. J Biomed Mater Res 1973;7:25–42.
[27] Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive
glass dissolution increase proliferation of human osteoblasts and induce
9182 S. Midha et al. / Acta Biomaterialia 9 (2013) 9169–9182insulin-like growth factor II mRNA expression and protein synthesis. Biochem
Biophys Res Commun 2000;276:461–5.
[28] Xynos I, Hukkanen M, Batten J, Buttery L, Hench L, Polak J. Bioglass 45S5
stimulates osteoblast turnover and enhances bone formation in vitro:
implications and applications for bone tissue engineering. Calcif Tissue Int
2000;67:321–9.
[29] Jones JR, Tsigkou O, Coates EE, Stevens MM, Polak JM, Hench LL. Extracellular
matrix formation and mineralization on a phosphate-free porous bioactive
glass scaffold using primary human osteoblast (HOB) cells. Biomaterials
2007;28:1653–63.
[30] Loty C, Sautier J, Tan M, Oboeuf M, Jallot E, Boulekbache H, et al. Bioactive glass
stimulates in vitro osteoblast differentiation and creates a favourable template
for bone tissue formation. J Bone Miner Res 2001;16:231–9.
[31] Karpov M, Laczka M, Leboy PS, Osyczka AM. Sol–gel bioactive glasses support
both osteoblast and osteoclast formation from human bone marrow cells. J
Biomed Mater Res A 2008;84:718–26.
[32] Li R, Clark AE, Hench LL. An investigation of bioactive glass powders by sol–gel
processing. J Appl Biomater 1991;2:231–9.
[33] Pereira MM, Jones JR, Oreﬁce RL, Hench LL. Preparation of bioactive glass
polyvinyl alcohol hybrid foams by the sol–gel method. J Mater Sci Mater Med
2005;16:1045–50.
[34] Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M. Three-dimensional printing of
hierarchical and tough mesoporous bioactive glass scaffolds with a
controllable pore architecture, excellent mechanical strength and
mineralization ability. Acta Biomater 2011;7:2644–50.
[35] Gough JE, Jones JR, Hench LL. Nodule formation and mineralisation of human
primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials
2004;25:2039–46.
[36] Midha S, van den Bergh W, Kim TB, Lee PD, Jones JR, Mitchell CA. Bioactive
glass foam scaffolds are remodelled by osteoclasts and support the formation
of mineralized matrix and vascular networks in vitro. Adv Healthcare Mater
2013;2:490–9.
[37] Wheeler DL, Eschbach EJ, Hoellrich RG, Montfort MJ, Chamberland DL.
Assessment of resorbable bioactive material for grafting of critical-size
cancellous defects. J Orthop Res 2000;18:140–8.
[38] Wang S, Falk M, Rashad A, Saad M, Marques A, Almeida R, et al. Evaluation of
3D nano–macro porous bioactive glass scaffold for hard tissue engineering. J
Mater Sci Mater Med 2011;22:1195–203.
[39] Yun H, Park J, Kim S, Kim Y, Jang J. Effect of the pore structure of bioactive
glass balls on biocompatibility in vitro and in vivo. Acta Biomater
2011;7:2651–60.
[40] Ducheyne P, El-Ghannam A, Shapiro I. Effect of bioactive glass templates on
osteoblast proliferation and in vitro synthesis of bone-like tissue. J Cell
Biochem 1994;56:162–7.
[41] el-Ghannam A, Ducheyne P, Shapiro IM. Bioactive material template for
in vitro synthesis of bone. J Biomed Mater Res 1995;29:359–70.
[42] Garcia AJ, Ducheyne P, Boettiger D. Effect of surface reaction stage on
ﬁbronectin-mediated adhesion of osteoblast-like cells to bioactive glass. J
Biomed Mater Res 1998;40:48–56.
[43] Atwood R, Jones JR, Lee P, Hench LL. Analysis of pore interconnectivity in
bioactive glass foams using X-ray microtomography. Scr Mater
2004;51:1029–33.[44] Jones JR, Lee PD, Hench LL. Hierarchical porous materials for tissue
engineering. Philos Trans A Math Phys Eng Sci 2006;364:263–81.
[45] Yue S, Lee PD, Poologasundarampillai G, Jones JR. Evaluation of 3-D bioactive
glass scaffolds dissolution in a perfusion ﬂow system with X-ray
microtomography. Acta Biomater 2011;7:2637–43.
[46] Yue S, Lee PD, Poologasundarampillai G, Jones JR. Synchrotron X-ray
microtomography for assessment of bone tissue scaffolds. J Mater Sci Mater
Med 2010;21:847–53.
[47] Barber CB, Dobkin DP, Huhdanpaa H. The quickhuall algorithm for convex
hulls. ACM Trans Math Soft 1996;22:469–83.
[48] Hege HC, Seebass M, Stalling D, Zockler M. A generalized marching cubes
algorithm based on non-binary classiﬁcations. Technical report, Konrad-Zuse-
Zentrum (ZIB):SC; 1997:97–05.
[49] Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of
image analysis. Nat Methods 2012;9:671–5.
[50] Hench LL, Xynos ID, Polak JM. Bioactive glasses for in situ tissue regeneration. J
Biomater Sci Polym Ed 2004;15:543–62.
[51] Sepulveda P, Jones JR, Hench LL. In vitro dissolution of melt-derived 45S5 and
sol–gel derived 58S bioactive glasses. J Biomed Mater Res 2002;61:301–11.
[52] Hench LL, Polak JM. Third-generation biomedical materials. Science
2002;295:1014–7.
[53] Hing KA, Gibson I, Revell PA, Best S, Bonﬁeld W. Inﬂuence of phase purity on
the in vivo response to hydroxyapatite. Key Eng Mater 2000;192:373–6.
[54] Hing KA, Wilson LF, Buckland T. Comparative performance of three ceramic
bone graft substitutes. Spine J 2007;7:475–90.
[55] Galindo-Moreno P, Ávila G, Fernández-Barbero JE, Mesa F, O’Valle-Ravassa F,
Wang HL. Clinical and histologic comparison of two different composite grafts
for sinus augmentation: a pilot clinical trial. Clin Oral Implants Res
2008;19:755–9.
[56] Sun JY, Hao SC, Sun RB, Yang YS. Treatment of high-energy tibial shaft fractures
with internal ﬁxation and early prophylactic NovaBone grafting. Orthop Surg
2009;1:17–21.
[57] Hench LL. Genetic design of bioactive glass. J Eur Ceram Soc 2009;29:1257–65.
[58] Qiu Z, Yang H, Wu J, Wei L, Li J. Ionic dissolution products of NovaBone
promote osteoblastic proliferation via inﬂuences on the cell cycle. J Int Med
Res 2009;37:737–45.
[59] Patel N, Best S, Bonﬁeld W, Gibson I, Hing K, Damien E, et al. A comparative
study on the in vivo behavior of hydroxyapatite and silicon substituted
hydroxyapatite granules. J Mater Sci Mater Med 2002;13:1199–206.
[60] Patel N, Brooks R, Clarke M, Lee P, Rushton N, Gibson I, et al. In vivo assessment
of hydroxyapatite and silicate-substituted hydroxyapatite granules using an
ovine defect model. J Mater Sci Mater Med 2005;16:429–40.
[61] Porter AE, Patel N, Skepper JN, Best SM, Bonﬁeld W. Comparison of in vivo
dissolution processes in hydroxyapatite and silicon-substituted
hydroxyapatite bioceramics. Biomaterials 2003;24:4609–20.
[62] Ganz C, Xu W, Holzhüter G, Götz W, Vollmar B, Gerber T. Comparison of bone
substitutes in a tibia defect model in Wistar rats. Key Eng Mater
2012;493:732–8.
[63] Granito RN, Ribeiro DA, Rennó ACM, Ravagnani C, Bossini PS, Peitl-Filho O,
et al. Effects of biosilicate and bioglass 45S5 on tibial bone consolidation on
rats: a biomechanical and a histological study. J Mater Sci Mater Med
2009;20:2521–6.
